IBM's AI-driven growth prospects and moderate valuation make it an attractive investment, warranting a buy rating despite current economic uncertainties. Strong earnings with significant improvements in key metrics, particularly in the Software segment, showcase IBM's resilience and potential for future growth. New AI-focused chip architectures and the strategic acquisition of Accelalpha highlight IBM's commitment to leading the enterprise AI market.
The latest trading day saw IBM (IBM) settling at $217.16, representing a +1.1% change from its previous close.
IBM said on Wednesday it expects a pre-tax charge of nearly $2.7 billion in the third quarter, related to a transaction involving the transfer of some of its pension plan obligations to a unit of Prudential Financial.
As of Sept. 11, 2024, two stocks in the information technology sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
In the latest trading session, IBM (IBM) closed at $205.32, marking a +0.88% move from the previous day.
IBM is set to expand Oracle consulting expertise in the supply chain, logistics and finance with the Accelalpha buyout.
IBM announced Monday that it plans to acquire Accelalpha, a Bellevue, Wash.
International Business Machines Corporation (NYSE:IBM ) Goldman Sachs Communacopia + Technology Conference September 9, 2024 8:30 PM ET Company Participants Conference Call Participants James Schneider Okay. Good morning, everybody.
IBM appears to be treading in the middle of the road, and new investors could be better off if they trade with caution.
IBM has pivoted from a traditional tech company to an AI powerhouse. The Watson AI engine is designed to deliver reliable and traceable outputs -- just what enterprise-class corporate clients always wanted.
IBM's growth rates are stabilizing as it expands its hybrid cloud and AI services. Microsoft's cloud and AI businesses are still growing rapidly.
Zacks.com users have recently been watching IBM (IBM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.